Brevan Howard Capital Management LP Syndax Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 22,685 shares of SNDX stock, worth $296,719. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,685Holding current value
$296,719% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
230Shares Held
90MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$103 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$76.4 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$65.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$63.9 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$53.7 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $740M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...